Foley Represents Milwaukee Bucks in Development of High-Tech, Adjustable Thermal Bench
March 22, 2019
Foley & Lardner LLP represented the NBA’s Milwaukee Bucks in connection with its development of a high-tech, adjustable thermal bench for its players. The specifications for the customized performance seating was developed by the Bucks and designed to enhance on-court performance by maintaining elevated body temperature and proper anthropometrics when players are seated.
Foley’s representation included protecting the Bucks’ intellectual property and negotiating with Figueras Seating USA for the engineering and manufacture of seating meeting the Bucks’ specifications.
The state-of-art player bench can be heated to 106 degrees to maintain optimal muscle temperature. The seats can be individually elevated or lowered at a touch of button to accommodate player heights without blocking spectator sightlines.
Partner Aaron Tantleff and Special Counsel Matt Swietlik led the Foley team.
Read more about the Bucks’ famed bench here.
Foley’s representation included protecting the Bucks’ intellectual property and negotiating with Figueras Seating USA for the engineering and manufacture of seating meeting the Bucks’ specifications.
The state-of-art player bench can be heated to 106 degrees to maintain optimal muscle temperature. The seats can be individually elevated or lowered at a touch of button to accommodate player heights without blocking spectator sightlines.
Partner Aaron Tantleff and Special Counsel Matt Swietlik led the Foley team.
Read more about the Bucks’ famed bench here.
People
Related News
August 8, 2025
In the News
Gregory Husisian and David Simon Uncover the High Stakes of Tariff Evasion
Foley & Lardner LLP partners Gregory Husisian and David Simon are featured for their insights on how the U.S. government is cracking down on tariff evaders in the Newsweek article, "America Is Making Billions From Catching 'Tariff Cheaters.'"
August 7, 2025
In the News
Kyle Faget Weighs in on Trump Pharma Tariffs
Foley & Lardner LLP partner Kyle Faget assessed the Trump administration's implementation of import tariffs on the pharmaceutical industry in the Pharma Life Sciences article, "Trump's pharma import tariffs threaten drug pricing, generics."
August 5, 2025
In the News
Aaron Maguregui on Health Data Sharing Plan – 'I would expect the FTC to be heavily involved'
Foley & Lardner LLP partner Aaron Maguregui addressed a new health care data sharing initiative announced by the federal government in the Bloomberg Law article, "Digital Data-Sharing Plan Tests Limits of Health Privacy Rules."